IndraLab

Statements



reach
"JOSD2 deficiency inhibits tumor cell proliferation by reducing glycolysis, and its mRNA expression is related to the worst prognosis in NSCLC (Krassikova et al., 2021)."

eidos
"JOSD2 deficiency displays cytostatic effects and reduces glycolysis in a broad spectrum of tumor cells of distinct origin and its expression correlates with poor prognosis in non-small cell lung cancer ."

reach
"In addition, Krassikova et al. also demonstrated that JOSD2 promoted glycolysis in tumor cells through deubiquitination and stabilization of three important enzymes involved in glucose metabolism, namely PHGDH, PFK-1 and Aldolase A."

reach
"Krassikova et al. also demonstrated that JOSD2 promoted glycolysis in tumor cells through deubiquitination and stabilization of three important enzymes involved in glucose metabolism, namely PHGDH, PFK-1 and Aldolase A."